
Cysteamine: Can reduce melasma pigmentation in tested topical formulas. Zinc Oxide: Provides UV protection in tested sunscreens and wetness protection in barrier creams.


Consider for diagnosed melasma when a suitable topical option is needed.
Choose a broad-spectrum sunscreen you will use consistently, or a labelled barrier paste for wetness.
Can you use both?
Daily sunscreen is essential when using cysteamine for pigment.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.











Affects melanin formation: Cysteamine acts through several pigment pathways. May help melasma: The formula, contact time and tolerance matter.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Absorbs and scatters UV: Particles act in a film at the skin surface. The full sunscreen matters: Broad-spectrum protection depends on the formula.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Built from where each one usually sits in a routine. Introduce one at a time.
5% cysteamine cream is the main concentration studied for melasma. Contact time is product-specific; some studied formulas are short-contact treatments rather than overnight creams.
5%
Studied melasma cream
Controlled trials studied this strength. One short-contact trial used a specific cream; follow the current product’s instructions rather than copying a study schedule.
Choosing a strength: Choose a finished topical product with clear instructions for how long to leave it on and when to rinse.
Higher strengths: There is no established benefit from escalating beyond the studied strength. Burning, redness or a persistent rash are reasons to stop and reassess.
Formula matters: Stabilization, the base cream and exposure time affect tolerability. Different cysteamine formulations need not have identical instructions.
Zinc oxide sunscreen and thick barrier ointment have different jobs. U.S. sunscreen concentrations can be up to 25%; some skin-protectant ointments use more than 25% through 40%.
25%
25–40%
U.S. sunscreen ceiling
The permitted upper concentration is not an SPF rating. Choose a finished sunscreen by its tested protection.
Higher skin-protectant ointments
The monograph specifies more than 25% through 40% in ointments. These barrier products are not automatically sunscreens.
Choosing a strength: For sun protection, choose a tested broad-spectrum sunscreen with appropriate SPF. For a barrier ointment, choose its labeled protective purpose.
Higher strengths: More zinc oxide alone does not prove higher SPF, better UVA coverage or a better diaper-rash result.
Formula matters: Particle characteristics, dispersion and the full formula affect protection and feel. An unlabeled zinc paste should not be substituted for sunscreen.
Approximate windows, not promises.
First few weeksAssess tolerance first; pigment change is usually slower.
First few weeksProtection starts with correct application; it does not require a weeks-long course.
4–8 weeksSome studied regimens begin showing pigment improvement.
4–8 weeksConsistency matters; this is prevention, not a spot-clearing treatment.
8–12 weeksA useful review point for benefit and irritation.
8–12 weeksContinue correct application and reapplication.
3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.
3–6 monthsMonitor tolerance and sun exposure; a changing spot needs assessment.
6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.
6–12 monthsPhotoaging prevention is a long-term benefit, not a promise of wrinkle reversal.
Odour, stinging and irritation may limit use; follow wash-off instructions.
May leave a white cast or feel heavy; other formula ingredients can irritate.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Choose a simple formula and test a small area first. Individual tolerance matters more than an ingredient’s reputation for being gentle.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Data in pregnancy are limited; ask the clinician managing your pregnancy before using.
Mineral sunscreens are generally considered acceptable in pregnancy.
On the skin. The finished product delivers cysteamine in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Acts on pigment-related pathways; the cream, contact time and tolerance influence its practical effect.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
On the skin. The finished product delivers zinc oxide in a particular vehicle.
Entering skin. Formula-unit mass is not particle size. These mineral particles act in the surface sunscreen film; the 500 Da guideline does not predict particle penetration.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Particles absorb and scatter UV at or near the surface; barrier pastes also shield skin from moisture and friction.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
Consider for diagnosed melasma when a suitable topical option is needed.
A small placebo-controlled study supports 5% cream over four months. Active-comparator studies are small and do not prove equal efficacy to hydroquinone. The mass shown refers to the free base, not its hydrochloride salt.
Choose a broad-spectrum sunscreen you will use consistently, or a labelled barrier paste for wetness.
Sun protection is established for tested sunscreen products, not loose zinc powder. Formula-unit mass is not particle size. A sunscreen ageing trial cannot isolate zinc oxide or prove reversal of existing wrinkles.
Sources